Cogent Biosciences, Inc. (COGT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:08AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 801.24M |
| Enterprise value | 606.18M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.00 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.89 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.06 |
| 52-week change 3 | -35.69% |
| S&P500 52-week change 3 | 23.33% |
| 52-week high 3 | 13.50 |
| 52-week low 3 | 3.67 |
| 50-day moving average 3 | 7.08 |
| 200-day moving average 3 | 7.69 |
Share statistics
| Avg vol (3-month) 3 | 1.39M |
| Avg vol (10-day) 3 | 1.27M |
| Shares outstanding 5 | 95.61M |
| Implied shares outstanding 6 | 95.61M |
| Float 8 | 71.06M |
| % held by insiders 1 | 0.14% |
| % held by institutions 1 | 115.99% |
| Shares short (15 May 2024) 4 | 13.46M |
| Short ratio (15 May 2024) 4 | 10.51 |
| Short % of float (15 May 2024) 4 | 15.84% |
| Short % of shares outstanding (15 May 2024) 4 | 14.08% |
| Shares short (prior month 15 Apr 2024) 4 | 12.47M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 09 Nov 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 09 Nov 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -38.43% |
| Return on equity (ttm) | -65.70% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -224.96M |
| Net income avi to common (ttm) | -212.17M |
| Diluted EPS (ttm) | -2.49 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 435.74M |
| Total cash per share (mrq) | 4.56 |
| Total debt (mrq) | 18.52M |
| Total debt/equity (mrq) | 4.39% |
| Current ratio (mrq) | 12.05 |
| Book value per share (mrq) | 2.09 |
Cash flow statement
| Operating cash flow (ttm) | -166.64M |
| Levered free cash flow (ttm) | -90.8M |
© 2024 Yahoo. All rights reserved.